Ferritin, a potent threat for acute myocardial infarction?

Journal of Association of Physicians of India

Volumn 51, Issue OCT, 2003, Pages 947-950

  Wilma Delphine Silvia, C R ^a   Biswas, Sharmistha ^a   Uthappa, Sheila ^a   Shetty, P ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; FERRITINS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 1242263936     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Salonen JT, Nyyssonen K, Korpela H, Tuomilehito J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 1992;86:803-11.
2. Esterbauer II, Gebicki J, Phul II, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modifcation of LDL. J Free Radical Biological Med 1992;13:341-90.
3. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981;1:1293-94.
4. Klipstein-Grobusch K, Koster JF, Grobbee DE, et al. Serum ferritin and risk of myocardial infarction in the elderly : the Rotterdam study. Am J Clin Nutr 1999;69:1231-36.
5. Ascherio A, Willett WC, Rimm EB, Giovannucci EL, Stampfer MJ. Dietary iron intake and risk of coronary disease among men. Circulation 1994;89:969-74.
6. McCord JM. Is iron sufficiency a risk factor in ischaemic heart disease? Circulation 1991;83:1112-14.
7. Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-7.
8. Araujo JA, Romano EL, Brito BE, et al. Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vasc Biol 1995;15:1172-80.
9. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochem J 1992;286:901-5.
10. Cook JD, Lipschitz DA, Miles LEM, Finch CM. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 1974;27:681-7.
11. Beaton GH, Corey PN, Steele C. Conceptual and methodological issues regarding the epidemiology of iron deficiency and their implications for studies of the functional consequences of iron deficiency. Am J Clin Nutr 1989;50:575-85.
12. Rifai N, Bachorik PS, Albers JJ. Lipids lipoproteins and apolipoproteins. In: Burtis CA and Ashwood ER, editors. Tietz Text Book of Clinical Biochemistry. Philadelphia : WB Saunders company, 1999;809-61.
13. Sempos CT, Looker AC, Gillum RF. Iron and heart disease : the epidemiologic data. Nutr Rev 1996;54:73-84.
14. Salonen JT, Nyyssonen K, Salonen R. Body iron stores and the risk of coronry heart disease. NEJM 1994;331:1159-60.
15. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis. Prospective results from the Bruneck study. Circulation 1997;96:3300-7.
16. Meyer DG, Strickland D, Maloeley PA, Seburg JJ, Wilson JE, McManus BF. Possible association of a reduction in cardiovascular events with blood donation. Heart 1997;78:188-93.
17. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979;76:333-7.
18. Cathcart MK, Morel DW, Chisolm GM III. Monocytes and neutrophils oxidize low density lipoproteins making it cytotoxic. J Leukocyte Biol 1985;38:341-50.
19. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modiciation of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Nati Acad Sci USA 1984;83:3883-7.
20. Steinbrecher UP, Witztum JL, Parthasarathy S, Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL : correlation with changes in receptor-mediated catabolism. Arteriosclerosis 1987;1:135-43.